{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:20:10Z","timestamp":1789089610019,"version":"build-2803163510"},"reference-count":155,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007029","name":"Higher Education and Science Committee of the Ministry of Education Science Culture and Sports of the Republic of Armenia","doi-asserted-by":"publisher","award":["SCS 21AG-1F072"],"award-info":[{"award-number":["SCS 21AG-1F072"]}],"id":[{"id":"10.13039\/501100007029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.autrev.2026.104034","type":"journal-article","created":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T15:53:16Z","timestamp":1773589996000},"page":"104034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Angiogenic imbalance and endothelial dysfunction in the placenta in antiphospholipid syndrome"],"prefix":"10.1016","volume":"25","author":[{"given":"A.","family":"Martirosyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kriegova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Manukyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2\u20133","key":"10.1016\/j.autrev.2026.104034_bb0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.placenta.2003.10.004","article-title":"Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation","volume":"25","author":"Charnock-Jones","year":"2004","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.autrev.2026.104034_bb0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.acthis.2007.02.008","article-title":"Vasculogenesis and angiogenesis in the early human placenta","volume":"109","author":"Demir","year":"2007","journal-title":"Acta Histochem"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20060339","article-title":"Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches","volume":"113","author":"Jansson","year":"2007","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"10.1016\/j.autrev.2026.104034_bb0020","doi-asserted-by":"crossref","DOI":"10.1242\/dev.204838","article-title":"Feto-placental blood vessel development","volume":"152","author":"Kalisch-Smith","year":"2025","journal-title":"Development"},{"issue":"5302","key":"10.1016\/j.autrev.2026.104034_bb0025","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.autrev.2026.104034_bb0030","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1530\/REP-09-0092","article-title":"Regulation of vascular growth and function in the human placenta","volume":"138","author":"Burton","year":"2009","journal-title":"Reproduction"},{"issue":"7983","key":"10.1016\/j.autrev.2026.104034_bb0035","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41586-023-06604-5","article-title":"Complete human day 14 post-implantation embryo models from naive ES cells","volume":"622","author":"Oldak","year":"2023","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.autrev.2026.104034_bb0040","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.autrev.2026.104034_bb0045","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/ncomms1977","article-title":"The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis","volume":"24","author":"Cudmore","year":"2012","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.autrev.2026.104034_bb0050","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0008-6363(00)00281-9","article-title":"Molecular mechanisms of blood vessel growth","volume":"49","author":"Conway","year":"2001","journal-title":"Cardiovasc Res"},{"issue":"9","key":"10.1016\/j.autrev.2026.104034_bb0055","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.placenta.2008.06.009","article-title":"The distribution of angiopoietin-1, angiopoietin-2 and their receptors tie-1 and tie-2 in the very early human placenta","volume":"29","author":"Seval","year":"2008","journal-title":"Placenta"},{"issue":"16","key":"10.1016\/j.autrev.2026.104034_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169010","article-title":"Comparison of the behavior of perivascular cells (Pericytes and CD34+ stromal cell\/Telocytes) in sprouting and intussusceptive angiogenesis","volume":"23","author":"D\u00edaz-Flores","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.autrev.2026.104034_bb0065","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/plac.2002.0865","article-title":"Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells","volume":"23","author":"Mayhew","year":"2002","journal-title":"Placenta"},{"issue":"2S","key":"10.1016\/j.autrev.2026.104034_bb0070","doi-asserted-by":"crossref","first-page":"S745","DOI":"10.1016\/j.ajog.2017.11.577","article-title":"Pathophysiology of placental-derived fetal growth restriction","volume":"218","author":"Burton","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl A","key":"10.1016\/j.autrev.2026.104034_bb0075","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1053\/plac.2002.0815","article-title":"Adriana and Luisa Castellucci Award lecture 2001. Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies--a review","volume":"23","author":"Caniggia","year":"2002","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.autrev.2026.104034_bb0080","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41374-020-00513-1","article-title":"Vascular remodeling by placenta-derived mesenchymal stem cells restores ovarian function in ovariectomized rat model via the VEGF pathway","volume":"101","author":"Cho","year":"2021","journal-title":"Lab Invest."},{"issue":"5","key":"10.1016\/j.autrev.2026.104034_bb0085","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1067\/mob.2002.127305","article-title":"The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature","volume":"187","author":"Brosens","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104034_bb0090","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.1002\/jcp.30470","article-title":"Novel insights for the role of nitric oxide in placental vascular function during and beyond pregnancy","volume":"236","author":"Krause","year":"2021","journal-title":"J Cell Physiol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104034_bb0095","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1007\/s43032-020-00212-8","article-title":"Regulation of uterine spiral artery remodeling: a review","volume":"27","author":"Albrecht","year":"2020","journal-title":"Reprod Sci"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0100","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1186\/s12884-020-03150-0","article-title":"Spiral artery blood flow during pregnancy: a systematic review and meta-analysis","volume":"20","author":"Schiffer","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2S","key":"10.1016\/j.autrev.2026.104034_bb0105","doi-asserted-by":"crossref","first-page":"S895","DOI":"10.1016\/j.ajog.2020.09.026","article-title":"Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia","volume":"226","author":"Staff AC","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/plac.2002.0867","article-title":"Expression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts","volume":"24","author":"Isaka","year":"2003","journal-title":"Placenta"},{"issue":"151","key":"10.1016\/j.autrev.2026.104034_bb0115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.theriogenology.2020.02.002","article-title":"Matrix metalloproteinases improves trophoblast invasion and pregnancy potential in mice","volume":"15","author":"Zhang","year":"2020","journal-title":"Theriogenology"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1478-811X-2-4","article-title":"Regulation of trophoblast beta1-integrin expression by contact with endothelial cells","volume":"2","author":"Thirkill","year":"2004","journal-title":"Cell Commun Signal"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0125","article-title":"The regulation of placental pericyte function through transforming growth factor \u03b2-1 signalling","volume":"15","author":"CA","year":"2025","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0130","doi-asserted-by":"crossref","DOI":"10.1242\/dev.181263","article-title":"Low oxygen enhances trophoblast column growth by potentiating differentiation of the extravillous lineage and promoting LOX activity","volume":"147","author":"Treissman","year":"2020","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0135","doi-asserted-by":"crossref","first-page":"F53","DOI":"10.1530\/REP-20-0153","article-title":"HYPOXIA AND REPRODUCTIVE HEALTH: oxygen and development of the human placenta","volume":"161","author":"Burton","year":"2021","journal-title":"Reproduction"},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.autrev.2026.104034_bb0145","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.autrev.2026.104034_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01388","article-title":"Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications","volume":"9","author":"Tedesco","year":"2018","journal-title":"Front Immunol"},{"issue":"SI","key":"10.1016\/j.autrev.2026.104034_bb0155","doi-asserted-by":"crossref","first-page":"SI4","DOI":"10.1093\/rheumatology\/kead603","article-title":"Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?","volume":"63","author":"Raschi","year":"2024","journal-title":"Rheumatology (Oxford)."},{"issue":"12","key":"10.1016\/j.autrev.2026.104034_bb0160","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1093\/rheumatology\/keae178","article-title":"Can complement activation be the missing link in antiphospholipid syndrome?","volume":"63","author":"Venturelli","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104034_bb0165","article-title":"Mechanism of antiphospholipid antibody-mediated thrombosis in antiphospholipid syndrome","volume":"16","author":"Yang","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104034_bb0170","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104034_bb0175","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11926-021-01051-5","article-title":"An update on antiphospholipid syndrome","volume":"23","author":"Xourgia","year":"2022","journal-title":"Curr Rheumatol Rep"},{"issue":"5\u20136","key":"10.1016\/j.autrev.2026.104034_bb0180","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0143-4004(97)80040-9","article-title":"Synthesis of beta2 glycoprotein 1 by the human placenta","volume":"18","author":"Chamley","year":"1997","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.autrev.2026.104034_bb0185","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/ard.2004.021444","article-title":"Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro","volume":"64","author":"Di Simone","year":"2005","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0190","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-0897.2009.00717.x","article-title":"Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4\/MyD88 pathway","volume":"62","author":"Mulla","year":"2009","journal-title":"Am J Reprod Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104034_bb0195","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.4049\/jimmunol.161.4.2038","volume":"161","author":"Sheng","year":"1998","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2141.2000.01976.x","article-title":"Monovalent binding of autoantibodies to beta2-glycoprotein I, detected using surface plasmon resonance at low antigen density","volume":"109","author":"Regnault","year":"2000","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1191\/0961203303lu280oa","article-title":"Anti-beta2-glycoprotein I autoantibodies require an antigen density threshold, consistent with divalent binding","volume":"12","author":"Reddel","year":"2003","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.autrev.2026.104034_bb0210","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.autrev.2026.104034_bb0215","first-page":"1840","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006 Sep 7;355(10):992\u20131005","volume":"355","author":"Levine","year":"2006","journal-title":"Erratum in: N Engl J Med"},{"issue":"21","key":"10.1016\/j.autrev.2026.104034_bb0220","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.autrev.2026.104034_bb0225","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0230","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/uog.26032","article-title":"Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction","volume":"61","author":"Stepan","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0235","doi-asserted-by":"crossref","first-page":"108.e1","DOI":"10.1016\/j.ajog.2015.09.066","article-title":"Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study","volume":"214","author":"Kim","year":"2016","journal-title":"Am J Obstet Gynecol."},{"issue":"5","key":"10.1016\/j.autrev.2026.104034_bb0240","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3324\/haematol.2016.155184","article-title":"Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes","volume":"102","author":"Cochery-Nouvellon","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.autrev.2026.104034_bb0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jri.2018.04.002","article-title":"Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosus","volume":"127","author":"Mayer-Pickel","year":"2018","journal-title":"J Reprod Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0250","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1095\/biolreprod.110.083410","article-title":"Antiphospholipid antibodies affect human endometrial angiogenesis","volume":"83","author":"Di Simone","year":"2010","journal-title":"Biol Reprod"},{"issue":"4","key":"10.1016\/j.autrev.2026.104034_bb0255","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1600-0897.2011.01007.x","article-title":"Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin","volume":"66","author":"Carroll","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2026.104034_bb0260","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.preghy.2018.01.008","article-title":"The role of angiogenic biomarkers and uterine artery Doppler in pregnant women with systemic lupus erythematosus or antiphospholipid syndrome","volume":"11","author":"Rodr\u00edguez-Almaraz","year":"2018","journal-title":"Pregnancy Hypertens"},{"issue":"15","key":"10.1016\/j.autrev.2026.104034_bb0265","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1182\/blood-2011-01-333617","article-title":"In vivo distribution of \u03b22 glycoprotein I under various pathophysiologic conditions","volume":"118","author":"Agostinis","year":"2011","journal-title":"Blood"},{"issue":"9133","key":"10.1016\/j.autrev.2026.104034_bb0270","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(05)60080-3","article-title":"Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death","volume":"352","author":"Chamley","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0275","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P","article-title":"Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I","volume":"43","author":"Di Simone","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2026.104034_bb0280","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/jth.12570","article-title":"Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies","volume":"12","author":"Marchetti","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.autrev.2026.104034_bb0285","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.fertnstert.2004.07.978","article-title":"Antiphospholipid antibodies prevent extravillous trophoblast differentiation","volume":"83","author":"Quenby","year":"2005","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.autrev.2026.104034_bb0290","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/art.39453","article-title":"ApoE receptor 2 mediation of trophoblast dysfunction and pregnancy complications induced by antiphospholipid antibodies in mice","volume":"68","author":"Ulrich","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104034_bb0295","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Y","article-title":"Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype","volume":"44","author":"Meroni","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2026.104034_bb0300","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2002-08-2349","article-title":"Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies","volume":"101","author":"Raschi","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.autrev.2026.104034_bb0305","article-title":"Antiphospholipid antibodies induce proinflammatory and procoagulant pathways in endothelial cells","volume":"2","author":"Patsouras","year":"2023","journal-title":"J Transl Autoimmun"},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0310","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/01.ATV.20.2.563","article-title":"Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells","volume":"20","author":"Galve-de Rochemonteix","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104034_bb0315","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1182\/blood-2011-03-344671","article-title":"A novel pathway for human endothelial cell activation by antiphospholipid\/anti-\u03b22 glycoprotein I antibodies","volume":"119","author":"Allen","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.autrev.2026.104034_bb0320","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/ard-2023-224930","article-title":"Single-cell transcriptome analyses reveal disturbed decidual homoeostasis in obstetric antiphospholipid syndrome","volume":"83","author":"Lu","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0325","doi-asserted-by":"crossref","first-page":"31163","DOI":"10.1038\/s41598-024-82451-2","article-title":"Impact of antiphospholipid syndrome on placenta and uterine NK cell function: insights from a mouse model","volume":"14","author":"Martirosyan","year":"2024","journal-title":"Sci Rep"},{"issue":"41","key":"10.1016\/j.autrev.2026.104034_bb0330","article-title":"Deciphering the role and mechanism of Decidual monocyte-derived macrophage infiltration in obstetric antiphospholipid syndrome at single-cell resolution","volume":"12","author":"Gao","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"10.1016\/j.autrev.2026.104034_bb0335","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00281-022-00916-w","article-title":"Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome","volume":"44","author":"Knight","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2026.104034_bb0340","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.thromres.2022.05.001","article-title":"Association between neutrophil extracellular traps (NETs) and thrombosis in antiphospholipid syndrome","volume":"214","author":"Mazetto","year":"2022","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.autrev.2026.104034_bb0345","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1093\/rheumatology\/keaf204","article-title":"Anti-\u03b22glycoprotein I-induced neutrophil extracellular traps cause endothelial activation","volume":"64","author":"Mancuso","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.autrev.2026.104034_bb0350","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1111\/jcmm.15321","article-title":"Antiphospholipid antibody-activated NETs exacerbate trophoblast and endothelial cell injury in obstetric antiphospholipid syndrome","volume":"24","author":"Lu","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0355","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1186\/s12967-025-06596-y","article-title":"Antiphospholipid antibodies inhibit the migration and invasion of trophoblast cells by suppressing the JNK\/C-Jun\/MMP1 signaling pathway","volume":"23","author":"Wang","year":"2025","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.autrev.2026.104034_bb0360","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1172\/JCI68107","article-title":"Uterine NK cells: active regulators at the maternal-fetal interface","volume":"124","author":"Moffett","year":"2014","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.autrev.2026.104034_bb0365","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ni.3131","article-title":"Immune mechanisms at the maternal-fetal interface: perspectives and challenges","volume":"16","author":"PrabhuDas","year":"2015","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104034_bb0370","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.humimm.2021.01.012","article-title":"Molecular and immunological developments in placentas","volume":"82","author":"Nakashima","year":"2021","journal-title":"Hum Immunol"},{"issue":"25","key":"10.1016\/j.autrev.2026.104034_bb0375","article-title":"Macrophage at maternal-fetal Interface: perspective on pregnancy and related disorders","volume":"S0143-4004","author":"Duan","year":"2025","journal-title":"Placenta"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2026.104034_bb0380","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jri.2012.04.003","article-title":"The correlation of autoantibodies and uNK cells in women with reproductive failure","volume":"95","author":"Mariee","year":"2012","journal-title":"J Reprod Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104034_bb0385","first-page":"366","article-title":"Screeningov\u00e9 vy\u0161et\u0159en\u00ed endometri\u00e1ln\u00edch NK bun\u011bk u vybran\u00fdch infertiln\u00edch pacientek 1. \u010d\u00e1st - metodika a pr\u016fb\u011b\u017en\u00e9 v\u00fdsledky [Screening of endometrial NK cells in selected infertile patients First part - Methods and current results]","volume":"82","author":"Ul\u010dov\u00e1-Gallov\u00e1","year":"2017","journal-title":"Ceska Gynekol"},{"issue":"13","key":"10.1016\/j.autrev.2026.104034_bb0390","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood-2006-04-017343","article-title":"Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function","volume":"108","author":"Vacca","year":"2006","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.autrev.2026.104034_bb0395","article-title":"Uterine natural killer cells: A rising star in human pregnancy regulation","volume":"1","author":"Xie","year":"2022","journal-title":"Front Immunol"},{"issue":"7731","key":"10.1016\/j.autrev.2026.104034_bb0400","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-018-0698-6","article-title":"Single-cell reconstruction of the early maternal-fetal interface in humans","volume":"563","author":"Vento-Tormo","year":"2018","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.autrev.2026.104034_bb0405","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.immuni.2018.03.030","article-title":"Trained memory of human uterine NK cells enhances their function in subsequent pregnancies","volume":"48","author":"Gamliel","year":"2018","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0410","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cmet.2018.07.008","article-title":"Sweet killers: NK cells need glycolysis to kill tumors","volume":"28","author":"Isaacson","year":"2018","journal-title":"Cell Metab"},{"issue":"16","key":"10.1016\/j.autrev.2026.104034_bb0740","doi-asserted-by":"crossref","first-page":"1593705","DOI":"10.3389\/fimmu.2025.1593705","article-title":"NK cell dysfunction in antiphospholipid syndrome","volume":"12","author":"Martirosyan","year":"2025","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104034_bb0415","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1046\/j.1365-2249.2003.02092.x","article-title":"Phenotypic characterization of human decidual macrophages","volume":"131","author":"Heikkinen","year":"2003","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0420","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/imr.13080","article-title":"Monocytes and macrophages in pregnancy: the good, the bad, and the ugly","volume":"308","author":"True","year":"2022","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0425","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1182\/blood-2012-03-378646","article-title":"The significance of autoantibodies against \u03b22-glycoprotein I","volume":"120","author":"de Groot","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.autrev.2026.104034_bb0430","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/art.22802","article-title":"Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts","volume":"56","author":"Sorice","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"14","key":"10.1016\/j.autrev.2026.104034_bb0435","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1182\/blood-2008-11-188698","article-title":"Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo","volume":"114","author":"Romay-Penabad","year":"2009","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.autrev.2026.104034_bb0440","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/blood-2011-09-378851","article-title":"Autoantibodies specific to a peptide of \u03b22-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes","volume":"120","author":"Colasanti","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0445","doi-asserted-by":"crossref","first-page":"41433","DOI":"10.1038\/s41598-025-25472-9","article-title":"Inhibition of FKBP5 alleviates obstetric antiphospholipid syndrome by regulating macrophage polarization","volume":"15","author":"Song","year":"2025","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2006.10.879","article-title":"Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies","volume":"196","author":"Shamonki","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104034_bb0455","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/path.2893","article-title":"Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss","volume":"225","author":"Cohen","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.autrev.2026.104034_bb0460","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.placenta.2025.07.088","article-title":"Complement proteins, annexin V, and angiogenic markers in placental tissue of autoimmune disease patients","volume":"170","author":"Castellanos Gutierrez","year":"2025","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.autrev.2026.104034_bb0465","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/biomedicines9060671","article-title":"Low preconception complement levels are associated with adverse pregnancy outcomes in a multicenter study of 260 pregnancies in 197 women with antiphospholipid syndrome or carriers of antiphospholipid antibodies","volume":"9","author":"Nalli","year":"2021","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.autrev.2026.104034_bb0470","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1084\/jem.20061022","article-title":"Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction","volume":"203","author":"Girardi","year":"2006","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.autrev.2026.104034_bb0475","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood-2007-01-070631","article-title":"Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury","volume":"110","author":"Redecha","year":"2007","journal-title":"Blood"},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2026.104034_bb0480","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1177\/096120339800700218","article-title":"Placental pathology in antiphospholipid syndrome","volume":"7","author":"Levy","year":"1998","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/j.autrev.2026.104034_bb0485","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-2007-994176","article-title":"Placental pathology and antiphospholipid antibodies: a descriptive study","volume":"14","author":"Salafia","year":"1997","journal-title":"Am J Perinatol"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2026.104034_bb0490","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.placenta.2005.04.006","article-title":"The placental bed in pregnancies complicated by primary antiphospholipid syndrome","volume":"27","author":"Stone","year":"2006","journal-title":"Placenta"},{"issue":"7","key":"10.1016\/j.autrev.2026.104034_bb0495","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.placenta.2003.12.006","article-title":"Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes","volume":"25","author":"Van Horn","year":"2004","journal-title":"Placenta"},{"key":"10.1016\/j.autrev.2026.104034_bb0500","doi-asserted-by":"crossref","DOI":"10.3389\/flupu.2024.1459172","article-title":"Placental lesions in patients with antiphospholipid antibody syndrome: experience of a single tertiary-care Italian reference center","volume":"2","author":"Canti","year":"2024","journal-title":"Front Lupus"},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0505","first-page":"258","article-title":"Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients","volume":"101","author":"Sebire","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104034_bb0515","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.autrev.2026.104034_bb0520","doi-asserted-by":"crossref","DOI":"10.1002\/acr2.70122","article-title":"IgG and IgM anti-phosphatidylserine\/prothrombin complex antibody detection may improve Classification accuracy of systemic lupus erythematosus and antiphospholipid antibody syndrome","volume":"7","author":"Donath","year":"2025","journal-title":"ACR Open Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0525","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/biomedicines9020166","article-title":"Current promising biomarkers and methods in the diagnostics of antiphospholipid syndrome: A review","volume":"9","author":"Bradacova","year":"2021","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0530","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0897.2005.00294.x","article-title":"Anti-phospholipid antibodies against phosphatidylinositol, and phosphatidylserine are more significant in reproductive failure than antibodies against cardiolipin only","volume":"54","author":"Ulcova-Gallova","year":"2005","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2026.104034_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109804","article-title":"Beyond the classics: the emerging value of anti-phosphatidylserine\/prothrombin antibodies in antiphospholipid syndrome","volume":"256","author":"Ding","year":"2023","journal-title":"Clin Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104034_bb0510","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3899\/jrheum.170751","article-title":"Antiphosphatidylserine\/prothrombin antibodies in antiphospholipid syndrome with intrauterine growth restriction and preeclampsia","volume":"45","author":"Canti","year":"2018","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104034_bb0535","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1095\/biolreprod53.4.905","article-title":"Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line","volume":"53","author":"Adler","year":"1995","journal-title":"JAR Biol Reprod"},{"issue":"10","key":"10.1016\/j.autrev.2026.104034_bb0545","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"380","key":"10.1016\/j.autrev.2026.104034_bb0550","article-title":"Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management","volume":"27","author":"Knight","year":"2023","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.autrev.2026.104034_bb0555","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1055\/s-0036-1592336","article-title":"Pregnancy and antiphospholipid syndrome","volume":"42","author":"Schreiber","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0560","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.path.2022.02.001","article-title":"Life after Amsterdam: placental pathology consensus recommendations and beyond","volume":"15","author":"Slack","year":"2022","journal-title":"Surg Pathol Clin"},{"issue":"8","key":"10.1016\/j.autrev.2026.104034_bb0565","article-title":"Enhancing the diagnostic accuracy of placental pathology by using the Amsterdam consensus Criteria","volume":"16","author":"Alturkustani","year":"2024","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.autrev.2026.104034_bb0570","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","article-title":"Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement","volume":"140","author":"Khong","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.autrev.2026.104034_bb0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000676","article-title":"The haemodynamics of the human placenta in utero","volume":"18","author":"Dellschaft","year":"2020","journal-title":"PLoS Biol"},{"issue":"34","key":"10.1016\/j.autrev.2026.104034_bb0585","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw9753","article-title":"High-resolution MRI reveals uteroplacental flow dynamics in a 3D-printed human placental cotyledon model","volume":"11","author":"Barapatre","year":"2025","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0590","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-2003-38833","article-title":"Procoagulant and anticoagulant mechanisms in human placenta","volume":"29","author":"Lanir","year":"2003","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0595","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/jaut.2000.0410","article-title":"Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome","volume":"15","author":"Rand","year":"2000","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.autrev.2026.104034_bb0600","first-page":"646","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndromeJ Clin Invest. 2003 Dec;112(11):1644\u201354. doi:10.1172\/JCI18817","volume":"113","author":"Girardi","year":"2003","journal-title":"Erratum in: J Clin Invest"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0605","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ajog.2005.05.034","article-title":"Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses","volume":"194","author":"Rand","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0610","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13293-018-0195-5","article-title":"Pro-angiogenic therapeutics for preeclampsia","volume":"9","author":"Eddy","year":"2018","journal-title":"Biol Sex Differ"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0615","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s43856-024-00642-4","article-title":"Biomarkers and point of care screening approaches for the management of preeclampsia","volume":"4","author":"Ng","year":"2024","journal-title":"Commun Med (Lond)"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0620","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12884-024-06263-y","article-title":"sFlT-1\/PlGF ratio as a predictor of preeclampsia in COVID-19 pregnant patients","volume":"24","author":"Pluta","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"issue":"23","key":"10.1016\/j.autrev.2026.104034_bb0625","first-page":"9219","article-title":"Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13438\u201343. doi:10.1073\/pnas.1016546108. Epub 2011 Aug 1","volume":"109","author":"Webber","year":"2012","journal-title":"Erratum in: Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.autrev.2026.104034_bb0630","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bcp.2012.04.011","article-title":"Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis","volume":"84","author":"Finetti","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104034_bb0635","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/rb\/rbz027","article-title":"Enhanced angiogenesis by the hyaluronic acid hydrogels immobilized with a VEGF mimetic peptide in a traumatic brain injury model in rats","volume":"6","author":"Lu","year":"2019","journal-title":"Regen Biomater"},{"key":"10.1016\/j.autrev.2026.104034_bb0640","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2023.06.017","article-title":"VEGF mimetic peptide-conjugated nanoparticles for magnetic resonance imaging and therapy of myocardial infarction","volume":"360","author":"Li","year":"2023","journal-title":"J Control Release"},{"issue":"7","key":"10.1016\/j.autrev.2026.104034_bb0645","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1046\/j.1538-7836.2003.00263.x","article-title":"Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders","volume":"1","author":"Autiero","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"9","key":"10.1016\/j.autrev.2026.104034_bb0650","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1253\/circj.CJ-08-1067","article-title":"Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarction","volume":"73","author":"Takeda","year":"2009","journal-title":"Circ J"},{"issue":"4","key":"10.1016\/j.autrev.2026.104034_bb0655","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/HYPERTENSIONAHA.115.06783","article-title":"Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension","volume":"67","author":"Spradley","year":"2016","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.autrev.2026.104034_bb0660","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/HYPERTENSIONAHA.116.07286","article-title":"Placental growth factor reduces blood pressure in a Uteroplacental ischemia model of preeclampsia in nonhuman Primates","volume":"67","author":"Makris","year":"2016","journal-title":"Hypertension"},{"issue":"6B","key":"10.1016\/j.autrev.2026.104034_bb0665","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1582-4934.2009.00820.x","article-title":"Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model","volume":"14","author":"Bergmann","year":"2010","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0670","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/s41598-017-01993-w","article-title":"Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment","volume":"7","author":"Hannan","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.autrev.2026.104034_bb0675","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206814","article-title":"Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome","volume":"13","author":"Urbanski","year":"2018","journal-title":"PloS One"},{"issue":"25","key":"10.1016\/j.autrev.2026.104034_bb0680","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1080\/14767058.2021.1943656","article-title":"Effect of hydroxychloroquine on antiphospholipid antibodies-inhibited endometrial angiogenesis","volume":"35","author":"Dong","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.autrev.2026.104034_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117968","article-title":"S-hydroxychloroquine prevents the antiphospholipid thrombogenic complexes for antiphospholipid syndrome treatment","volume":"186","author":"Hsieh","year":"2025","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.autrev.2026.104034_bb0690","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/annrheumdis-2013-203622","article-title":"A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients","volume":"73","author":"Erkan","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2026.104034_bb0695","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1538-7836.2004.00801.x","article-title":"Aspirin inhibits endothelial cell activation induced by antiphospholipid antibodies","volume":"2","author":"Dunoyer-Geindre","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2026.104034_bb0700","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/humupd\/dml051","article-title":"Pathogenic role of anti-beta2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin","volume":"13(2)","author":"Di Simone","year":"2007","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.autrev.2026.104034_bb0705","doi-asserted-by":"crossref","unstructured":"Di Simone N, D'Ippolito S, Marana R, Di Nicuolo F, Castellani R, Pierangeli SS, Chen P, Tersigni C, Scambia G, Meroni PL. Antiphospholipid antibodies affect human endometrial angiogenesis: protective effect of a synthetic peptide (TIFI) mimicking the phospholipid binding site of \u03b2(2) glycoprotein I. Am J Reprod Immunol 2013 Oct;70(4):299\u2013308. doi:https:\/\/doi.org\/10.1111\/aji.12130. Epub 2013 May 7. PMID: 23650919.","DOI":"10.1111\/aji.12130"},{"issue":"13","key":"10.1016\/j.autrev.2026.104034_bb0710","article-title":"PEGylated domain I of Beta-2-glycoprotein I inhibits thrombosis in a chronic mouse model of the antiphospholipid syndrome","volume":"11","author":"Willis","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104034_bb0715","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1191\/0961203306lu2315oa","article-title":"A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice","volume":"15","author":"Ostertag","year":"2006","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0720","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/ajt.12540","article-title":"Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation","volume":"14","author":"Lonze","year":"2014","journal-title":"Am J Transplant"},{"issue":"40","key":"10.1016\/j.autrev.2026.104034_bb0725","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012584","article-title":"Eculizumab in a pregnant patient with laboratory onset of catastrophic antiphospholipid syndrome: A case report","volume":"97","author":"Rovere-Querini","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.autrev.2026.104034_bb0730","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1160\/TH14-07-0628","article-title":"Cofactor-independent antiphospholipid antibodies activate the NLRP3-inflammasome via endosomal NADPH-oxidase: implications for the antiphospholipid syndrome","volume":"113","author":"M\u00fcller-Calleja","year":"2015","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.autrev.2026.104034_bb0735","first-page":"891","article-title":"Antiphospholipid antibodies inhibit trophoblast toll-like receptor and Inflammasome negative regulators. Arthritis","volume":"70","author":"Mulla","year":"2018","journal-title":"Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104034_bb0745","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/humrep\/deu014","article-title":"Adoptive transfer of pregnancy-induced CD4+CD25+ regulatory T cells reverses the increase in abortion rate caused by interleukin 17 in the CBA\/JxBALB\/c mouse model","volume":"29","author":"Wang","year":"2014","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0750","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1038\/s41598-018-25574-7","article-title":"A phase I clinical trial with ex vivo expanded recipient regulatory T cells in living donor kidney transplants","volume":"8","author":"Mathew","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.autrev.2026.104034_bb0755","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/annrheumdis-2019-215396","article-title":"Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial","volume":"79","author":"He","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"18","key":"10.1016\/j.autrev.2026.104034_bb0760","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147474","article-title":"The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes","volume":"6","author":"Dong","year":"2021","journal-title":"JCI Insight"},{"issue":"14","key":"10.1016\/j.autrev.2026.104034_bb0765","doi-asserted-by":"crossref","first-page":"1256453","DOI":"10.3389\/fimmu.2023.1256453","article-title":"Regulatory T cell adoptive transfer alters uterine immune populations, increasing a novel MHC-IIlow macrophage associated with healthy pregnancy","volume":"13","author":"Lewis","year":"2023","journal-title":"Front Immunol"},{"issue":"13","key":"10.1016\/j.autrev.2026.104034_bb0770","article-title":"Human-induced CD49a+ NK cells promote fetal growth","volume":"4","author":"Du","year":"2022","journal-title":"Front Immunol"},{"issue":"16","key":"10.1016\/j.autrev.2026.104034_bb0775","doi-asserted-by":"crossref","first-page":"1520619","DOI":"10.3389\/fimmu.2025.1520619","article-title":"\u03b22GPI-targeted polymeric nanoparticles form a protective layer to prevent vascular thrombosis in an anti-phospholipid syndrome model","volume":"27","author":"Durigutto","year":"2025","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104034_bb0780","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/01.RES.88.2.245","article-title":"Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin","volume":"88","author":"Pierangeli","year":"2001","journal-title":"Circ Res"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226000480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226000480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:14:21Z","timestamp":1776194061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997226000480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":155,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1568997226000480"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104034","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiogenic imbalance and endothelial dysfunction in the placenta in antiphospholipid syndrome","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104034"}}